Updated software improves slicing for large-format 3D printing
Anne Campbell, an R&D associate at ORNL, has been selected for an Emerging Professional award from ASTM International. ASTM, formerly the American Society for Testing and Materials, is an international standards organization that develops and publishes voluntary consensus technical standards for a wide range of materials, products, systems and services.
A method using augmented reality to create accurate visual representations of ionizing radiation, developed at ORNL, has been licensed by Teletrix, a firm that creates advanced simulation tools to train the nation’s radiation control workforce.
Valentino “Tino” Cooper, a scientist at ORNL, has been appointed to DOE’s Basic Energy Sciences Advisory Committee for a three-year term. Cooper’s research elucidates the fundamental understanding of advanced materials for next-generation energy and information technologies.
Andrew Lupini, a scientist and inventor at ORNL, has been elected Fellow of the Microscopy Society of America.
Marm Dixit, a Weinberg Distinguished Staff Fellow at ORNL has received the 2023 Rosalind Franklin Young Investigator Award.
Researchers at ORNL have developed a machine-learning inspired software package that provides end-to-end image analysis of electron and scanning probe microscopy images.
ORNL has named Michael Parks director of the Computer Science and Mathematics Division within ORNL’s Computing and Computational Sciences Directorate. His hiring became effective March 13.
Ho Nyung Lee, a condensed matter physicist at the Department of Energy’s Oak Ridge National Laboratory, has been elected a Fellow of the Materials Research Society.
Mickey Wade has been named associate laboratory director for the Fusion and Fission Energy and Science Directorate at the Department of Energy’s Oak Ridge National Laboratory, effective April 1.
A team of scientists led by the Department of Energy’s Oak Ridge National Laboratory designed a molecule that disrupts the infection mechanism of the SARS-CoV-2 coronavirus and could be used to develop new treatments for COVID-19 and other viral diseases.